Lumos Pharma, Inc.

Ownership Transactions Reported by 13 Insiders

Symbol
LUMO on Nasdaq
Location
4200 Marathon Blvd., Suite 200, Austin, TX

Insiders trading volume in the past year

Lumos Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Richard J. Hawkins Chief Executive Officer, Director $2.15M Apr 1, 2024
Pisit Duke Pitukcheewanont Chief Medical Officer $38.1K Jul 1, 2024
David B. Karpf Chief Medical Officer $26.6K Feb 1, 2023
John C. McKew Chief Scientific Officer $23.9K -$13.9K -36.8% Aug 6, 2024
Lori D. Lawley Chief Financial Officer $22K Aug 1, 2024
Aaron Schuchart Chief Business Officer $19K Apr 1, 2024
Bradley J. Powers General Counsel $18K Apr 1, 2024
Kevin M. Lalande Director Jun 5, 2024
Joseph S. McCracken Director Jun 5, 2024
Chad Allen Johnson Director Jun 5, 2024
Thomas A. Raffin Director Jun 5, 2024
An van Es-Johansson Director Jun 5, 2024
Lota S. Zoth Director Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Lumos Pharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.